Source-reported fields
Literal source text
General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; drug importation; and drug shortages. Drug pricing proposals. The 340B program. Pharmacy benefit manager reform proposals. H.R. 1; issues related to biopharmaceutical drug pricing, particularly related to MFN.
Literal federal measure citations: H.R. 1
Tax issues affecting the pharmaceutical industry including international tax; including tax issues under consideration for reconciliation legislation and H.R. 1, One Big Beautiful Bill Act". Vaccine excise tax issues and VICP.
Literal federal measure citations: H.R. 1
Medicare payment issues and Medicaid issues. Medicare Part D. Drug pricing proposals. Protecting Seniors Through Immunization Act. Pharmacy benefit manager reform proposals. H.R. 1, One Big Beautiful Bill Act, issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.
Literal federal measure citations: H.R. 1
Issues related to pharmaceutical manufacturing and development, trade and tariffs; potential tariff actions under Section 232 of the Trade Act of 1962.
Policies impacting post pandemic public health emergency Covid-19 vaccine reimbursement and distribution. Support for immunization access.
Issues related to pharmaceutical manufacturing and development.
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.
